Efficacy and Safety of Pembrolizumab in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.

Cancer InvestJun 5, 2026 (epub)
Clinical ResearchOncology (Medical)Gastroenterology

Kunhong Tang, Wei Zheng Huang, Jiaqi Wei et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the efficacy and safety of pembrolizumab in 4,560 patients with advanced gastric cancer. The study found that pembrolizumab significantly improved overall survival and objective response rate compared to control treatments, although progression-free survival showed no significant difference. Importantly, pembrolizumab did not increase the risk of treatment-related death (OR = 0.99, 95% CI 0.59-1.65).

Key findings

  • Pembrolizumab significantly improved overall survival and objective response rate compared to control treatments.
  • No significant difference in progression-free survival was observed.
  • The risk of treatment-related death was comparable to chemotherapy (OR = 0.99, 95% CI 0.59-1.65).
  • Combination therapy showed superior efficacy but higher immune-related toxicity.

Why it matters

The findings provide important insights into the safety and efficacy of pembrolizumab, addressing concerns about immunotherapy in advanced gastric cancer. Understanding the benefits and risks can guide treatment decisions and improve patient outcomes.

Source

PubMed · PMID 42246227

Published in Cancer Invest. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.